Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.86 |
| ▸ | CHAT | P28329 | 2/20 | 0.82 |
| ▸ | EP300 | Q09472 | 3/20 | 0.81 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.81 |
| ▸ | AURKA | O14965 | 2/20 | 0.81 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.81 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29359732 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29359942 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Succinic Acid SCHEMBL29713569 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL851130 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL15984379 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29652062 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29403288 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29424683 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29652056 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29351815 | 0.99 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3362567-B1 | GENETICALLY ENGINEERED BACTERIUM COMPRISING ENERGY-GENERATING FERMENTATION PATHWAY | LANZATECH NZ INC (US) | 2026-05-06 | — | — | EP | claimed |
| US-12577594-B2 | Engineered microorganisms and methods for improved aldehyde dehydrogenase activity | GENOMATICA, INC. (US) | 2026-03-17 | — | — | US | claimed |
| US-12577591-B2 | Microorganisms and methods for increasing co-factors | GENOMATICA, INC. (US) | 2026-03-17 | — | — | US | claimed |
| US-20260035705-A1 | ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | AGAIN BIO APS (DK) | 2026-02-05 | — | — | US | claimed |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | AGAIN BIO APS (DK) | 2026-01-29 | — | — | US | claimed |
| US-12529078-B2 | Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis | GENOMATICA, INC. (US) | 2026-01-20 | — | — | US | claimed |
| US-12503711-B2 | Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism | GENOMATICA, INC. (US) | 2025-12-23 | — | — | US | claimed |
| EP-4642908-A2 | LIGASE AND DEHYDROGENASE VARIANTS AND METHODS OF USE | Genomatica, Inc. (US) | 2025-11-05 | — | — | EP | claimed |
| US-12275979-B2 | Gene-modified microorganism for producing 3-hydroxyadipic acid, alpha-hydromuconic acid, and/or adipic acid, and production method for said chemical products | TORAY INDUSTRIES, INC. (JP) | 2025-04-15 | — | — | US | claimed |
| WO-2025063258-A1 | GENE-MODIFIED MICROORGANISM FOR PRODUCING α-HYDROMUCONIC ACID AND/OR ADIPIC ACID AND METHOD FOR PRODUCING SAID CHEMICAL PRODUCT | 東レ株式会社 | 2025-03-27 | — | — | WO | claimed |
| CN-114901815-A | Microorganisms and methods for increasing cofactors | 基因组股份公司 | 2022-08-12 | — | — | CN | claimed |
| US-20220235385-A1 | ENGINEERED MICROORGANISMS AND METHODS FOR IMPROVED ALDEHYDE DEHYDROGENASE ACTIVITY | AGAIN BIO APS (DK) | 2022-07-28 | — | — | US | claimed |
| CN-114728871-A | Microorganisms and methods for reducing by-products | 基因组股份公司 | 2022-07-08 | — | — | CN | claimed |
| US-20220213514-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYHEXANEDIOIC ACID, (E)-HEX-2-ENEDIOIC ACID AND/OR HEXANEDIOIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICALS | TORAY INDUSTRIES, INC. (JP) | 2022-07-07 | — | — | US | claimed |
| US-20220177895-A1 | ENGINEERED MICROORGANISMS WITH G3P -> 3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | AGAIN BIO APS (DK) | 2022-06-09 | — | — | US | claimed |
| CN-114341344-A | Engineered microorganisms and methods for improving aldehyde dehydrogenase activity | 基因组股份公司 | 2022-04-12 | — | — | CN | claimed |
| US-11293026-B2 | Microorganisms for the production of adipic acid and other compounds | GENOMATICA, INC. (US) | 2022-04-05 | — | — | US | claimed |
| CN-114269908-A | Engineered trans-enoyl COA reductase and preparation method and using method thereof | 基因组股份公司 | 2022-04-01 | — | — | CN | claimed |
| EP-3967762-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYHEXANEDIOIC ACID, (E)-HEX-2-ENEDIOIC ACID AND/OR HEXANEDIOIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICALS | Toray Industries, Inc. (JP) | 2022-03-16 | — | — | EP | claimed |
| EP-3959327-A1 | ENGINEERED TRANS-ENOYL COA REDUCTASE AND METHODS OF MAKING AND USING | Genomatica, Inc. (US) | 2022-03-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529078-B2 | Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis | ALDOA, FDPS, DERA | NAA50 298/4885CHAT 1363/4885EP300 1390/4885 |
| US-12577594-B2 | Engineered microorganisms and methods for improved aldehyde dehydrogenase activity | ACADM, ALDH7A1, ADSL | NAA50 211/4885CHAT 350/4885EP300 1233/4885 |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | DDC, DAO, ODC1 | NAA50 69/4885CHAT 77/4885EP300 1948/4885 |
| US-12577591-B2 | Microorganisms and methods for increasing co-factors | ABAT, HADHB, MMAB | NAA50 278/4885CHAT 1499/4885EP300 3766/4885 |
| US-20260035705-A1 | ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | ME1, FBP1, ME3 | NAA50 2772/4885CHAT 1142/4885EP300 3078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.